Details for Patent: 10,561,651
✉ Email this page to a colleague
Which drugs does patent 10,561,651 protect, and when does it expire?
Patent 10,561,651 protects ROZLYTREK and is included in one NDA.
This patent has twenty-six patent family members in twenty countries.
Summary for Patent: 10,561,651
Title: | Methods for treating neuroblastoma |
Abstract: | Methods of treating neuroblastoma associated with a deregulated protein kinase activity are disclosed. The treatment may include administration of substituted indazole derivatives of formula (I) or formula 2.(I) and pharmaceutically acceptable salts therefor, as degined in the specification. |
Inventor(s): | Lim; Jonathan (San Diego, CA), Ardini; Elena (Sesto san Giovanni, IT), Menichincheri; Maria (Milan, IT) |
Assignee: | IGNYTA, INC. (San Diego, CA) NERVIANO MEDICAL SCIENCES, S.R.L. (Nerviano (MI), IT) |
Application Number: | 16/050,516 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,561,651
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genentech Inc | ROZLYTREK | entrectinib | CAPSULE;ORAL | 212725-001 | Aug 15, 2019 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF NEUROBLASTOMAS THAT HAVE A NEUROTROPHIC TYROSINE RECEPTOR KINASE (NTRK) GENE FUSION | ⤷ Try a Trial | ||||
Genentech Inc | ROZLYTREK | entrectinib | CAPSULE;ORAL | 212725-002 | Aug 15, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF NEUROBLASTOMAS THAT HAVE A NEUROTROPHIC TYROSINE RECEPTOR KINASE (NTRK) GENE FUSION | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,561,651
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2015220832 | ⤷ Try a Trial | |||
Brazil | 112016015818 | ⤷ Try a Trial | |||
Canada | 2933623 | ⤷ Try a Trial | |||
Chile | 2016001507 | ⤷ Try a Trial | |||
China | 106029073 | ⤷ Try a Trial | |||
Eurasian Patent Organization | 033457 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |